Rapid remission of life-threatening chylo-ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co-variation.
- DOI
- 10.1002/pbc.31342
- Published
- 2024-09-22
- Container
- Pediatr Blood Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pbc.31342,
title = {Rapid remission of life-threatening chylo-ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co-variation.},
author = {Yuan M and Königs I and Reinshagen K and Ambs JM and Rutkowski S and Kordes UR.},
year = {2024},
journal = {Pediatr Blood Cancer},
doi = {10.1002/pbc.31342},
url = {https://doi.org/10.1002/pbc.31342}
}RIS
TY - JOUR TI - Rapid remission of life-threatening chylo-ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co-variation. AU - Yuan M AU - Königs I AU - Reinshagen K AU - Ambs JM AU - Rutkowski S AU - Kordes UR. PY - 2024 JO - Pediatr Blood Cancer DO - 10.1002/pbc.31342 UR - https://doi.org/10.1002/pbc.31342 ER -
APA
M, Y., I, K., K, R., JM, A., S, R., & UR., K. (2024). Rapid remission of life-threatening chylo-ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co-variation.. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.31342
Source records
- europe-pmc · retrieved 2026-09-27T05:19:48.018Z